238 related articles for article (PubMed ID: 18354225)
1. Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.
Hamel K; Doodes P; Cao Y; Wang Y; Martinson J; Dunn R; Kehry MR; Farkas B; Finnegan A
J Immunol; 2008 Apr; 180(7):4994-5003. PubMed ID: 18354225
[TBL] [Abstract][Full Text] [Related]
2. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.
Angyal A; Egelston C; Kobezda T; Olasz K; László A; Glant TT; Mikecz K
Arthritis Res Ther; 2010; 12(2):R44. PubMed ID: 20298547
[TBL] [Abstract][Full Text] [Related]
3. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
4. B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis.
Hamel KM; Cao Y; Ashaye S; Wang Y; Dunn R; Kehry MR; Glant TT; Finnegan A
J Immunol; 2011 Nov; 187(9):4900-6. PubMed ID: 21948985
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis.
O'Neill SK; Cao Y; Hamel KM; Doodes PD; Hutas G; Finnegan A
J Immunol; 2007 Oct; 179(8):5109-16. PubMed ID: 17911596
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
Glant TT; Radacs M; Nagyeri G; Olasz K; Laszlo A; Boldizsar F; Hegyi A; Finnegan A; Mikecz K
Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
[TBL] [Abstract][Full Text] [Related]
7. Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice.
Kis-Toth K; Radacs M; Olasz K; van Eden W; Mikecz K; Glant TT
Int Immunol; 2012 Aug; 24(8):507-17. PubMed ID: 22518822
[TBL] [Abstract][Full Text] [Related]
8. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
[TBL] [Abstract][Full Text] [Related]
9. T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system.
Bárdos T; Mikecz K; Finnegan A; Zhang J; Glant TT
J Immunol; 2002 Jun; 168(12):6013-21. PubMed ID: 12055209
[TBL] [Abstract][Full Text] [Related]
10. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases.
Pers YM; Jorgensen C
Immunotherapy; 2016 Sep; 8(9):1091-6. PubMed ID: 27485081
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis.
O'Neill SK; Shlomchik MJ; Glant TT; Cao Y; Doodes PD; Finnegan A
J Immunol; 2005 Mar; 174(6):3781-8. PubMed ID: 15749919
[TBL] [Abstract][Full Text] [Related]
13. CD19: a promising B cell target for rheumatoid arthritis.
Tedder TF
Nat Rev Rheumatol; 2009 Oct; 5(10):572-7. PubMed ID: 19798033
[TBL] [Abstract][Full Text] [Related]
14. B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis.
Olalekan SA; Cao Y; Hamel KM; Finnegan A
Eur J Immunol; 2015 Apr; 45(4):988-98. PubMed ID: 25645456
[TBL] [Abstract][Full Text] [Related]
15. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity.
Yanaba K; Hamaguchi Y; Venturi GM; Steeber DA; St Clair EW; Tedder TF
J Immunol; 2007 Jul; 179(2):1369-80. PubMed ID: 17617630
[TBL] [Abstract][Full Text] [Related]
16. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis.
Doodes PD; Cao Y; Hamel KM; Wang Y; Rodeghero RL; Mikecz K; Glant TT; Iwakura Y; Finnegan A
J Immunol; 2010 Feb; 184(3):1552-9. PubMed ID: 20028652
[TBL] [Abstract][Full Text] [Related]
18. B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4
Tanaka A; Ide K; Tanaka Y; Ohira M; Tahara H; Ohdan H
Sci Rep; 2021 Sep; 11(1):18180. PubMed ID: 34518640
[TBL] [Abstract][Full Text] [Related]
19. Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.
Kurkó J; Vida A; Ocskó T; Tryniszewska B; Rauch TA; Glant TT; Szekanecz Z; Mikecz K
PLoS One; 2014; 9(11):e111815. PubMed ID: 25369029
[TBL] [Abstract][Full Text] [Related]
20. T cell activation in rheumatoid synovium is B cell dependent.
Takemura S; Klimiuk PA; Braun A; Goronzy JJ; Weyand CM
J Immunol; 2001 Oct; 167(8):4710-8. PubMed ID: 11591802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
